United Services Automobile Association Amicus Therapeutics, Inc. Transaction History

United Services Automobile Association

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$8.02 - $13.25 $299,146 - $494,225	-37,300 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$10.96 - $14.4 $42,941 - $56,419	3,918 Added 11.74%	37,300 $466,000
Q1 2019 May 13, 2019	BUY	$10.04 - $13.92 $50,701 - $70,296	5,050 Added 17.82%	33,382 $454,000
Q1 2018 May 14, 2018	BUY	$13.76 - $17.12 $389,848 - $485,043	28,332 New	28,332 $426,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.